申请人:LG Life Sciences Ltd.
公开号:US08288386B2
公开(公告)日:2012-10-16
The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
本发明涉及一种对黑色素细胞素受体具有良好激动作用的化合物,或其药学上可接受的盐或异构体,以及包含其作为活性成分的黑色素细胞素受体激动剂组合物。